Pfizer : PFE

All Pfizer Articles

1516 Articles

Lee Jackson | Jul 6, 2026 at 7:52 AM EDT

Here Are Monday’s Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More

Pre-Market Stock Futures: Futures are trading mixed as we get ready to start the first full week of trading for…

Vandita Jadeja | Jul 2, 2026 at 11:02 AM EDT

$500 a Month in These Stocks Will Generate $6,700 in Passive Annual Income

Passive income is the paycheck that arrives whether you show up or not. Wages depend on a functioning employer, a…

Alex Sirois | Jun 30, 2026 at 12:47 PM EDT

3 Dirt-Cheap Stocks Under $45 Built to Outperform in a Volatile Market

Volatility can lower the cost of entry into businesses that throw off real cash, even as investors recognize that a…

Alex Sirois | Jun 30, 2026 at 12:15 PM EDT

Wall Street Walked Away From This Powerhouse Stock, But I Am Buying It on Repeat

I keep buying Pfizer (NYSE:PFE | PFE Price Prediction) every time my brokerage cash builds up, and I am not…

Alex Sirois | Jun 30, 2026 at 9:50 AM EDT

This 7% Yielding Healthcare Powerhouse Belongs in Retirees’ Portfolios

Few large-cap dividends generate as much skepticism as Pfizer (NYSE:PFE | PFE Price Prediction). The stock trades at $24.37, and…

Alex Sirois | Jun 29, 2026 at 10:51 AM EDT

66 With $1.3 Million. Here Are 3 Hidden Gems to Target

At 66 with $1.3 million, the math is straightforward. A 5% blended yield throws off roughly $65,000 a year before…

David Moadel | Jun 26, 2026 at 12:01 PM EDT

Moderna Is Up 14% Today: Is It Outperforming Other Vaccine Stocks Like Merck and Pfizer?

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up 14% to $68 and change in afternoon trading Friday, extending…

Alex Sirois | Jun 23, 2026 at 1:55 PM EDT

Forget Novo Nordisk. Pfizer’s Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait

Everyone is still arguing about Novo Nordisk (NYSE:NVO | NVO Price Prediction), the Danish obesity juggernaut whose GLP-1 franchise turned…

Vandita Jadeja | Jun 22, 2026 at 4:02 PM EDT

Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow

Eli Lilly (NYSE: LLY | LLY Price Prediction) and Pfizer (NYSE: PFE) just delivered Q1 2026 results that read like…

Vandita Jadeja | Jun 21, 2026 at 11:30 AM EDT

Own 500 Shares of Pfizer and JNJ and Here’s Your Annual Dividend Income

Passive income is the closest thing investors have to financial gravity. It pulls in money whether you are at your…

David Moadel | Jun 16, 2026 at 3:21 PM EDT

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is jumping again. Shares are up 9% today, trading near $57 in the…

Vandita Jadeja | Jun 13, 2026 at 11:26 AM EDT

3 Stocks With a Yield Over 6% For Passive Income Investors

Passive income arrives while you sleep, commute, or vacation. That appeal drives dividend investing: a paycheck every quarter regardless of…

Alex Sirois | Jun 12, 2026 at 10:47 AM EDT

Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy

Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to own right now, a $1.02 trillion obesity…

Alex Sirois | Jun 11, 2026 at 2:26 PM EDT

This $25 Billion Acquisition Just Unlocked a New Era of Growth for Pfizer — and Why It’s a Flawless Safe-Haven for Retirees

Pfizer (NYSE:PFE | PFE Price Prediction) is in the middle of its biggest reinvention in a generation, leaning on the…

Alex Sirois | Jun 11, 2026 at 2:23 PM EDT

A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25

At $25.60, Pfizer (NYSE:PFE | PFE Price Prediction) sits in Hold territory on Wall Street’s consensus. The headline 6.7% dividend…

1 2 3 4 … 102

Pfizer : PFE

All Pfizer Articles

Here Are Monday’s Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More

$500 a Month in These Stocks Will Generate $6,700 in Passive Annual Income

3 Dirt-Cheap Stocks Under $45 Built to Outperform in a Volatile Market

Wall Street Walked Away From This Powerhouse Stock, But I Am Buying It on Repeat

This 7% Yielding Healthcare Powerhouse Belongs in Retirees’ Portfolios

66 With $1.3 Million. Here Are 3 Hidden Gems to Target

Moderna Is Up 14% Today: Is It Outperforming Other Vaccine Stocks Like Merck and Pfizer?

Forget Novo Nordisk. Pfizer’s Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait

Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow

Own 500 Shares of Pfizer and JNJ and Here’s Your Annual Dividend Income

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

3 Stocks With a Yield Over 6% For Passive Income Investors

Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy

This $25 Billion Acquisition Just Unlocked a New Era of Growth for Pfizer — and Why It’s a Flawless Safe-Haven for Retirees

A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here’s How to Retire There at 62 Without Touching Your Savings

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here's How to Retire There at 62 Without Touching Your Savings

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

Pfizer : PFE

All Pfizer Articles

Here Are Monday’s Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More

$500 a Month in These Stocks Will Generate $6,700 in Passive Annual Income

3 Dirt-Cheap Stocks Under $45 Built to Outperform in a Volatile Market

Wall Street Walked Away From This Powerhouse Stock, But I Am Buying It on Repeat

This 7% Yielding Healthcare Powerhouse Belongs in Retirees’ Portfolios

66 With $1.3 Million. Here Are 3 Hidden Gems to Target

Moderna Is Up 14% Today: Is It Outperforming Other Vaccine Stocks Like Merck and Pfizer?

Forget Novo Nordisk. Pfizer’s Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait

Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow

Own 500 Shares of Pfizer and JNJ and Here’s Your Annual Dividend Income

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

3 Stocks With a Yield Over 6% For Passive Income Investors

Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy

This $25 Billion Acquisition Just Unlocked a New Era of Growth for Pfizer — and Why It’s a Flawless Safe-Haven for Retirees

A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here’s How to Retire There at 62 Without Touching Your Savings

Featured Reads

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here's How to Retire There at 62 Without Touching Your Savings